Yssa DeWoody is co-founder of the Commission on Novel Technologies for Neurodevelopmental Copy Number Variants.

Yssa DeWoody
Co-founder
Commission on Novel Technologies for Neurodevelopmental Copy Number Variants
From this contributor
Lumping versus splitting with autism-linked variants: A conversation with Vanessa Vogel-Farley and Yssa DeWoody
Researchers have long studied subgroups of people who share genetic variants, but the newly formed ‘CNV Commission’ is also looking at people with shared traits across different neurodevelopmental conditions.

Lumping versus splitting with autism-linked variants: A conversation with Vanessa Vogel-Farley and Yssa DeWoody
Explore more from The Transmitter
Boosting SCN2A expression reduces seizures in mice
A modified form of CRISPR amps up expression of the gene—a strategy that could apply to other gene variations linked to autism.

Boosting SCN2A expression reduces seizures in mice
A modified form of CRISPR amps up expression of the gene—a strategy that could apply to other gene variations linked to autism.
Nikolay Kukushkin discusses his book, ‘One Hand Clapping: Unraveling the Mystery of the Human Mind’
He explains how meaning arises in the interactions found throughout nature and evolution, from molecules to minds.
Nikolay Kukushkin discusses his book, ‘One Hand Clapping: Unraveling the Mystery of the Human Mind’
He explains how meaning arises in the interactions found throughout nature and evolution, from molecules to minds.
ADSI, leucovorin, autism registry; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 October.

ADSI, leucovorin, autism registry; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 October.